M Broggini

Problems in the design of anticancer agents.

M D'Incalci, G Balconi, M Broggini, 1989, Cancer surveys.

Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer.

M Broggini, M. Broggini, E. Rulli, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients.

V Torri, M D'Incalci, M Broggini, 2000, Anticancer research.

A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate

A. M. Riley, M Broggini, M. Broggini, 2010, British Journal of Cancer.